Bank of Montreal’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-42,259
| Closed | -$1.24M | – | 3237 |
|
|
2024
Q3 | $1.24M | Buy |
+42,259
| New | +$1.24M | ﹤0.01% | 1693 |
|
|
2024
Q2 | – | Sell |
-42,288
| Closed | -$881K | – | 3589 |
|
|
2024
Q1 | $881K | Buy |
+42,288
| New | +$881K | ﹤0.01% | 1829 |
|
|
2023
Q3 | – | Sell |
-8,391
| Closed | -$262K | – | 3408 |
|
|
2023
Q2 | $262K | Buy |
+8,391
| New | +$262K | ﹤0.01% | 2681 |
|
|
2021
Q2 | – | Sell |
-1,885
| Closed | -$100K | – | 3774 |
|
|
2021
Q1 | $100K | Sell |
1,885
-7,951
| -81% | -$422K | ﹤0.01% | 3004 |
|
|
2020
Q4 | $754K | Buy |
9,836
+6,850
| +229% | +$525K | ﹤0.01% | 2075 |
|
|
2020
Q3 | $111K | Sell |
2,986
-2,045
| -41% | -$76K | ﹤0.01% | 2639 |
|
|
2020
Q2 | $135K | Buy |
5,031
+4,555
| +957% | +$122K | ﹤0.01% | 2582 |
|
|
2020
Q1 | $8K | Sell |
476
-5,547
| -92% | -$93.2K | ﹤0.01% | 3242 |
|
|
2019
Q4 | $105K | Buy |
6,023
+1,221
| +25% | +$21.3K | ﹤0.01% | 2964 |
|
|
2019
Q3 | $73K | Buy |
4,802
+812
| +20% | +$12.3K | ﹤0.01% | 2970 |
|
|
2019
Q2 | $83K | Buy |
+3,990
| New | +$83K | ﹤0.01% | 3008 |
|
|
2019
Q1 | – | Sell |
-648
| Closed | -$13K | – | 3948 |
|
|
2018
Q4 | $13K | Buy |
648
+333
| +106% | +$6.68K | ﹤0.01% | 3433 |
|
|
2018
Q3 | $7K | Buy |
315
+195
| +163% | +$4.33K | ﹤0.01% | 3699 |
|
|
2018
Q2 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 4001 |
|